Capricor Therapeutics, Inc. financial data

Symbol
CAPR on Nasdaq
Industry
Pharmaceutical Preparations
Location
8840 Wilshire Blvd, 2 Nd Floor, Beverly Hills, CA
State of incorporation
DE
Fiscal year end
December 31
Former names
Nile Therapeutics, Inc. (to 11/20/2013), SMI PRODUCTS INC (to 9/19/2007)
Latest financial report
10-Q - Q3 2024 - Nov 14, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 208 % +69.4%
Debt-to-equity 98.2 % -88.9%
Return On Equity -113 % +81.7%
Return On Assets -57 % +8.83%
Operating Margin -156 %

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 45.5M shares +47.7%
Common Stock, Shares, Outstanding 40.3M shares +56%
Entity Public Float 120M USD +44.8%
Common Stock, Value, Issued 40.3K USD +56%
Weighted Average Number of Shares Outstanding, Basic 33.1M shares +28.2%
Weighted Average Number of Shares Outstanding, Diluted 33.1M shares +28.2%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 23.2M USD -63.4%
Research and Development Expense 45.4M USD +38.5%
General and Administrative Expense 14M USD +15.2%
Operating Income (Loss) -36.1M USD -17.1%
Nonoperating Income (Expense) 2.04M USD +25.9%
Net Income (Loss) Attributable to Parent -34.1M USD -16.6%
Earnings Per Share, Basic -1.02 USD/shares +12.1%
Earnings Per Share, Diluted -1.02 USD/shares +12.1%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 68.4M USD +661%
Marketable Securities, Current 16.7M USD -14.8%
Cash, Cash Equivalents, and Short-term Investments 85M USD +198%
Assets, Current 85.8M USD +191%
Property, Plant and Equipment, Net 5.32M USD +3.42%
Operating Lease, Right-of-Use Asset 1.49M USD -32.6%
Assets 93M USD +150%
Contract with Customer, Liability, Current 13.1M USD -48.3%
Liabilities, Current 20.5M USD -37.8%
Contract with Customer, Liability, Noncurrent 0 USD -100%
Operating Lease, Liability, Noncurrent 835K USD -50.4%
Liabilities 24.7M USD -36.6%
Accumulated Other Comprehensive Income (Loss), Net of Tax 96.2K USD -15%
Retained Earnings (Accumulated Deficit) -193M USD -21.5%
Stockholders' Equity Attributable to Parent 68.3M USD
Liabilities and Equity 93M USD +150%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -1.27M USD -130%
Net Cash Provided by (Used in) Financing Activities 2.29M USD -41.2%
Net Cash Provided by (Used in) Investing Activities -9.5M USD -196%
Common Stock, Shares Authorized 100M shares +100%
Common Stock, Shares, Issued 40.3M shares +56%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 68.4M USD +661%
Interest Paid, Excluding Capitalized Interest, Operating Activities 0 USD
Operating Lease, Liability 1.65M USD -31.7%
Depreciation 1.36M USD +42.4%
Payments to Acquire Property, Plant, and Equipment 609K USD +75%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -34.1M USD -16.7%
Lessee, Operating Lease, Liability, to be Paid 1.78M USD -34.1%
Property, Plant and Equipment, Gross 8.56M USD +21.5%
Operating Lease, Liability, Current 814K USD +11.5%
Lessee, Operating Lease, Liability, to be Paid, Year Two 635K USD -30.2%
Lessee, Operating Lease, Liability, to be Paid, Year One 914K USD +3.11%
Operating Lease, Weighted Average Discount Rate, Percent 0.07 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 127K USD -54.6%
Lessee, Operating Lease, Liability, to be Paid, Year Three 635K USD +15.9%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 5M shares 0%
Lessee, Operating Lease, Liability, to be Paid, Year Four 546K USD -21.3%
Operating Lease, Payments 221K USD +11.1%
Preferred Stock, Shares Outstanding 0 shares
Depreciation, Depletion and Amortization 331K USD +44%
Share-based Payment Arrangement, Expense 9.33M USD +39.7%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%